Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1280
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01783587 | Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer | ||
| NCT03469258 | Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma | ||
| NCT00593008 | Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer | ||
| NCT04938232 | Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL | ||
| NCT01067287 | Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation | ||
| NCT01790932 | BKM120 For Triple Negative Breast Cancer | ||
| NCT03875716 | Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma | ||
| NCT00729638 | RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple Myeloma | ||
| NCT03485547 | Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | ||
| NCT04245176 | Genetic Testing for All Breast Cancer Patients (GET FACTS) | ||
| NCT00418093 | Oxaliplatin, Gemcitabine and Bevacizumab in Women With Recurrent Mullerian Carcinoma | ||
| NCT00165555 | Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma | ||
| NCT06692452 | Tazemetostat Plus CHOP in 1L T-cell Lymphoma | ||
| NCT00134706 | A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer | ||
| NCT03835819 | A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) | ||
| NCT01670500 | Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa | ||
| NCT06366347 | ALPINE: Maintenance Letrozole/Abemaciclib vs Pembrolizumab | ||
| NCT03534323 | Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS | ||
| NCT03291951 | FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study | ||
| NCT01339039 | Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma | ||
| NCT01173523 | Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer | ||
| NCT00136396 | Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease | ||
| NCT03910296 | Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain | ||
| NCT02950766 | NeoVax Plus Ipilimumab in Renal Cell Carcinoma | ||
| NCT03161431 | SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab | ||
| NCT00436072 | ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer | ||
| NCT01068769 | Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor | ||
| NCT01523977 | Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL | ||
| NCT04972253 | Phase I BLASST-3 Trial | ||
| NCT04701645 | Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer | ||
| NCT00487305 | Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma | ||
| NCT04781062 | Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer | ||
| NCT01112514 | Indocyanine Green Fluorescent Molecular Imaging of the Gastrointestinal Tract | ||
| NCT00834093 | A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma | ||
| NCT01167114 | STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer | ||
| NCT03833934 | Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance | ||
| NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | ||
| NCT00827359 | Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma | ||
| NCT02764541 | Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) | ||
| NCT02943642 | Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides | ||
| NCT04906096 | Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL | ||
| NCT00400946 | Treatment of Acute Lymphoblastic Leukemia in Children | ||
| NCT04497142 | Effect of Perampanel on Peritumoral Hyperexcitability in HGG | ||
| NCT06122896 | Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals | ||
| NCT00004081 | Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer | ||
| NCT01058239 | Bortezomib Plus Rituximab for EBV+ PTLD | ||
| NCT00181701 | Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin | ||
| NCT02853500 | Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies | ||
| NCT00768144 | Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma | ||
| NCT00804336 | Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors |
